The Stochastic RSI hovered near 5.82 / 6.85, rebounding from oversold levels. This indicated that selling momentum was fading ...

The premarket trading on Friday has seen the three stocks in this analysis looking very much like a choppy session is about ...

While it may be premature to project extremely optimistic levels like 29,000–30,000, given the strong technical structure and ...

Overview: Bitcoin price hovered close to $120,000 with bullish indications at the time of writing but short-term adjustments ...

USDCHFtook support near 200- 4H EMA and showed a minor pullback on board-based US dollar buying. Currently trading at 0.80434 ...

The cryptocurrency market continues its choppy price action, with Bitcoin dropping below the $105k level earlier today. Ether ...

According to experts, the Nifty 50 is expected to see a falling resistance trendline breakout (around 25,380), followed by 25 ...

DOGE’s price weak rebound faces pressure as long-term holders sell and price risks retesting its 13-month low.

Following in the footsteps of BTC, BNBUSD shed most of its gains. Having reached $1022intraday, it is now trading at about ...

As Bitcoin hovers around $108K, prediction markets flip bearish while short-term indicators confirm what bulls don't want to ...

The Israel-based company, which developed Elfabrio alongside Chiesi Global Rare Diseases, part of Italy-based Chiesi Group, had been seeking approval for a new, less frequent dosing regimen for ...

Protalix ( ($PLX) ) has issued an announcement. On October 17, 2025, Protalix BioTherapeutics and its partner Chiesi Global Rare Diseases ...